Product Overview
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), made up of 44 amino acids. It binds selectively to GHRH receptors in the pituitary and is studied in laboratory settings for its role in endogenous growth hormone release.
Its structure carries a trans-3-hexenoic acid modification at the N-terminus. This modification gives it greater stability than native GHRH and more resistance to enzymatic breakdown. Research on Tesamorelin has focused mainly on growth hormone pathways and metabolic regulation.
Important Note
This product is not approved for human consumption, medical or veterinary use, or diagnostic purposes. It is supplied for laboratory research only and should be handled by qualified professionals in a controlled research setting.
Specifications
| Specification | Detail |
|---|---|
| Sequence | trans-3-hexenoyl-GRF (1-44) amide |
| Molecular Weight | 5135.9 g/mol |
| Vial Content | 10mg |
| Form | Lyophilized powder |
| Storage | Store below –20°C. Keep away from light. |
| Vial | 2mL Type I borosilicate glass, 13mm butyl rubber stopper, tamper-evident aluminum crimp seal |
| Purity | 99%+ (HPLC-UV) |
| Heavy Metals (As, Cd, Pb, Hg) | Not detected |
| Lot Number | TGC-TESA-20260723 |
| Test Date | 05 Aug 2026 |
| Testing Lab | Janoshik |
| Lab Report | Janoshik #211922 (Verification Key: 4715CTZSJ3IJ) |
Features & Properties
- Synthetic 44-amino acid analogue of human GHRH
- Modified N-terminus for greater stability
- Selective agonist at pituitary GHRH receptors
- Studied in relation to endogenous growth hormone release
- Supplied as a sterile lyophilized powder for stability
Storage & Stability
- Store the lyophilized powder at –20°C, where it remains stable for up to 24 months
- Avoid repeated freeze–thaw cycles
- Keep away from light
Usage Restrictions
- For laboratory research use only
- Not approved for human consumption, medical or veterinary use, or diagnostic purposes
- Handling should be carried out by qualified professionals in controlled research settings
- Store securely and keep out of reach of children
- Do not handle during pregnancy or breastfeeding
Frequently Asked Questions
Q1. What does each vial contain?
Each vial contains 10mg of Tesamorelin in lyophilized (freeze-dried) form.
Q2. What is Tesamorelin?
It is a synthetic 44-amino acid analogue of growth hormone-releasing hormone (GHRH). An N-terminal modification gives it greater stability than native GHRH.
Q3. What does the product look like?
A fine white to off-white powder at the bottom of the vial.
Q4. How should it be stored?
Keep it at –20°C and away from light. Stored this way, the lyophilized powder remains stable for up to 24 months. Avoid freeze–thaw cycles.
Q5. Is the peptide sterile?
Vials are filled under sterile conditions. Sterile technique should still be followed once the vial is opened.
Q6. Is this product for human use?
No. It is for laboratory research only and is not intended for human, veterinary, or medical use.
Q7. Why is Tesamorelin studied in research?
It is studied in preclinical and experimental models for its role in growth hormone release, IGF-1 regulation, and metabolic pathways.
Q8. Has this lot been third-party tested?
Yes. Lot TGC-TESA-20260723 was tested by Janoshik on 05 Aug 2026 (Report #211922), with purity listed at 99%+ (HPLC-UV). The report can be viewed through the COA / Testing link on this page.
Q9. What are the packaging details?
Each vial is a 2mL Type I borosilicate glass vial, sealed with a 13mm butyl rubber stopper and a tamper-evident aluminum crimp seal.
Q10. Is it stable during shipping?
The lyophilized form remains stable at ambient shipping temperatures. Move it to –20°C storage as soon as it arrives.
